Conversely, the activation of TLR9 in B cells can induce a regulatory phenotype characterized by the release of IL-10, which dampens inflammation and protects mice from type 1 diabetes.651 Similar observations have been reported for cGAS. Here, TLR9 is linked to type 1 diabetes mellitus.